News
Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...
Issued by the African National Congress, ANC Headquarters, 54 Pixley ka Isaka Seme Street, Johannesburg, 2001. www.anc1912.org.za, 11 March 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback